NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 133 filers reported holding NOVAVAX INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $27,000 | -70.0% | 49,150 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $90,000 | -31.3% | 49,150 | -29.3% | 0.00% | 0.0% |
| Q3 2018 | $131,000 | +52.3% | 69,550 | +7.7% | 0.00% | 0.0% |
| Q2 2018 | $86,000 | -36.3% | 64,550 | +0.8% | 0.00% | -33.3% |
| Q1 2018 | $135,000 | +48.4% | 64,050 | -13.0% | 0.00% | +50.0% |
| Q4 2017 | $91,000 | +4.6% | 73,650 | -4.5% | 0.00% | 0.0% |
| Q3 2017 | $87,000 | +3.6% | 77,150 | +5.5% | 0.00% | 0.0% |
| Q2 2017 | $84,000 | -15.2% | 73,150 | -6.2% | 0.00% | 0.0% |
| Q1 2017 | $99,000 | -7.5% | 77,950 | -8.3% | 0.00% | 0.0% |
| Q4 2016 | $107,000 | -34.8% | 85,050 | +7.9% | 0.00% | -50.0% |
| Q3 2016 | $164,000 | -55.3% | 78,850 | +56.0% | 0.00% | -63.6% |
| Q2 2016 | $367,000 | +38.0% | 50,550 | -2.1% | 0.01% | +37.5% |
| Q1 2016 | $266,000 | – | 51,650 | +2582400.0% | 0.01% | – |
| Q2 2014 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2014 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |